Status:
COMPLETED
Oral Vitamin C for Correction of Anemia in Patients Receiving Peritoneal Dialysis
Lead Sponsor:
Unity Health Toronto
Conditions:
Anemia
Peritoneal Dialysis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
People with kidney failure are at risk for the development of anemia. Anemia is a decrease in the production of hemoglobin, a substance that carries oxygen in the blood. The majority of patients requi...
Detailed Description
Patients will be randomized in a 1:1 ratio to Vitamin C 500mg orally once daily or matching placebo for 3 months. Randomization codes will be kept by the Research Pharmacy and investigators and patien...
Eligibility Criteria
Inclusion
- Receiving peritoneal dialysis for 2 months
Exclusion
- Red blood cell folate \< 3.9 nmol/L
- Serum B12 \<110 pmol/L
- Bleeding, blood transfusions, acute liver disease in the previous 3 months
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00920413
Start Date
March 1 2002
Last Update
June 15 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Michael's Hospital
Toronto, Ontario, Canada, M5B 1W8